BioPorto A/S maintained earnings guidance for the year 2023. Based on the progress and results obtained in the first six months of 2023, the company maintains its financial guidance for 2023. Revenue of approximately DKK 30 million to DKK 33 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.79 DKK | +1.24% | +9.95% | -14.35% |
05-08 | BioPorto A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-08 | Bioporto A/S Provides Earnings Guidance for 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.35% | 99.01M | |
-4.62% | 12.32B | |
+8.48% | 5.87B | |
+28.39% | 5.52B | |
-6.28% | 4.29B | |
-52.84% | 3.16B | |
+12.93% | 2.72B | |
+28.84% | 2.23B | |
-3.80% | 2.37B | |
-4.64% | 1.87B |
- Stock Market
- Equities
- BIOPOR Stock
- News BioPorto A/S
- BioPorto A/S Maintains Earnings Guidance for the Year 2023